| Acquirer | Target | Price |
|---|---|---|
| Aspen Global Inc. | Rights to 7 anesthesia drugs | $520 million |
| Zimmer Biomet | LDR Holding Corporation | $1 billion |
| Premier Inc. | Lincare's specialty pharmacy business | $75 million |
| Takeda Pharmaceutical Company | License to Theravance's TD-8954 | $15 million |
| Merck & Co. | Afferent Pharmaceuticals | $500 million |
| Meridian Behavioral Health | Valhalla Place | N/A |
Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
